Our discovery that the administration of recombinant FGF-2 into mice post-infection with C. albicans significantly increased mortality compared to non-FGF-2-treated animals suggests that angiogenesis mediated by FGF-2 enhances the pathogenicity of C. albicans during a disseminated infection. Here, FGF2 is linked to infection.